Candela receives FDA clearance for treatment of leg veins.WAYLAND, Mass.--(BUSINESS WIRE)--April 5, 1995--Candela Laser Corp. (CLZR) announced today that it has received Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) clearance for its new ScleroLASER. The ScleroLASER is designed to treat leg veins, a condition that affects an estimated 30-40 percent of women and 6-15 percent of men in the United States. Currently, the most common therapy to treat leg veins is sclerotherapy sclerotherapy /scle·ro·ther·a·py/ (skler?o-ther´ah-pe) injection of a chemical irritant into a vein to produce inflammation and eventual fibrosis and obliteration of the lumen, as for treatment of hemorrhoids. , an invasive method involving needle injections of chemicals directly into the vessels. The new Candela candela (kăndĕ`lə), in weights and measures: see candle. A unit of measurement of the intensity of light. Part of the SI system of measurement, one candela (cd) is the monochromatic radiation of 540THz with a radiant intensity ScleroLASER selectively treats leg veins of various sizes with little or no permanent skin discoloration dis·col·or·a·tion n. 1. a. The act of discoloring. b. The condition of being discolored. 2. A discolored spot, smudge, or area; a stain. Noun 1. or reddening while leaving the healthy skin unharmed. According to clinical investigator, Dr. Roy Geronemus of New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. , "The Candela ScleroLASER system is an excellent adjunct to sclerotherapy. It can be used quickly and effectively on vessels up to 1 millimeter in size. Some 80 percent of all leg veins fall into this category; for the remaining 20 percent, sclerotherapy remains the treatment of choice." "Candela is now the only manufacturer offering physicians and their patients a non-invasive solution for the treatment of leg veins," said Gerard E. Puorro, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "The FDA clearance of this device allows us to expand into a new cosmetic market that is potentially larger than those we serve today. We are enthusiastic about this treatment and its future." The ScleroLASER is the latest addition to the Candela Precision Line of laser products that includes systems designed for the treatment of vascular and pigmented lesions and for the removal of tattoos. Founded in 1970, Candela Laser Corp. is recognized worldwide as a medical market innovator and dominant force in dermatology, plastic surgery and urology. CONTACT: Candela Laser Corp., Wayland Richard J. Olsen, 508/358-7637, ext. 224 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion